0001773751-24-000059.txt : 20240315 0001773751-24-000059.hdr.sgml : 20240315 20240315161246 ACCESSION NUMBER: 0001773751-24-000059 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240313 FILED AS OF DATE: 20240315 DATE AS OF CHANGE: 20240315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boughton Soleil CENTRAL INDEX KEY: 0001837817 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38986 FILM NUMBER: 24754882 MAIL ADDRESS: STREET 1: 2269 CHESTNUT STREET, #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Hims & Hers Health, Inc. CENTRAL INDEX KEY: 0001773751 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 BUSINESS PHONE: 415-851-0195 MAIL ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 FORMER COMPANY: FORMER CONFORMED NAME: Oaktree Acquisition Corp. DATE OF NAME CHANGE: 20190412 4 1 wk-form4_1710533549.xml FORM 4 X0508 4 2024-03-13 0 0001773751 Hims & Hers Health, Inc. HIMS 0001837817 Boughton Soleil 2269 CHESTNUT STREET, #523 SAN FRANCISCO CA 94123 0 1 0 0 Chief Legal Officer 1 Class A Common Stock 2024-03-13 4 M 0 63621 2.43 A 217966 D Class A Common Stock 2024-03-13 4 S 0 63621 15.1682 D 154345 D Stock Option (right to buy) 2.43 2024-03-13 4 M 0 63621 0 D 2030-05-12 Class A Common Stock 63621 113769 D The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 8, 2023 by the Reporting Person. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.00 - $15.375. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. The option award vests over a four year period, with 1/48 of the shares subject to the stock option vesting when the Reporting Person completes each month of continuous service beginning February 12, 2020. 100% of the shares subject to the option have vested. /s/ Alexandra Cotter Wilkins, Attorney-in-Fact 2024-03-15